Rx (Prescription Medicine)
USD $ 130.00
USD $ 4.33 per tablet
Les comprimés de tériflunomide Merosya 14 mg sont fabriqués par Intas Pharmaceuticals en Inde et contiennent 14 mg de tériflunomide par comprimé. Chaque plaquette thermoformée contient 30 comprimés, faisant de Merosya 14 mg une option efficace contre la sclérose en plaques. Une ordonnance est nécessaire pour obtenir ce médicament. Indogenmed propose tous les génériques du tériflunomide 14 mg.
| Brand Name | |
|---|---|
| Pack Quantity | 30 Tablets |
| Country Of Origin | India |
| Medicine Form | Tablet |
| Medicine Type | Generic |
| Molecule | |
| Packaging Type | Strip |
| Rx Status | Rx (Prescription Medicine) |
| Strength | 14 mg |
Seuls les clients connectés ayant acheté ce produit ont la possibilité de laisser un avis.
Autres marques de Teriflunomide 14 mg — le même ingrédient actif à la même force, d'un autre fabricant.
Revu médicalement par
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
Avis
Il n’y a pas encore d’avis.